Studies of KP46 and KP1019 and the Hydrolysis Product of KP1019 in Lipiodol Emulsions: Preparation and Initial Characterizations as Potential Theragnostic Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|15|1|134-142

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.15, Iss.1, 2018-01, pp. : 134-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pralmorelin: GHRP 2, GPA 748, Growth Hormone-Releasing Peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 4, 2004-01 ,pp. : 236-239

Adis International

Access to resources Recommend Favorite

KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts

By Furuta Sadayoshi   Hori Toshimitsu   Ohyama Tadashi  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 5, 2006-08 ,pp. : 360-366

Springer Publishing Company

Access to resources Recommend Favorite

Ribonucleotide Reductase as One Important Target of [Tris(1,10- phenanthroline)lanthanum(III)] Trithiocyanate (KP772)

By  

Current Cancer Drug Targets, Vol. 9, Iss. 5, 2009-08 ,pp. : 595-607

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 13, Iss. 5, 2013-06 ,pp. : 506-518

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Computational Studies on Aryloxypropyl Piperazine Derivatives as Potential Atypical Antipsychotic Agents

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 2, 2012-02 ,pp. : 218-224

Bentham Science Publishers

Access to resources Recommend Favorite